ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets common cancer driver in first human trial
Disease control Recruiting nowThis is an early-stage study testing a new drug called BGB-53038, which is designed to block a specific protein (KRAS) that drives the growth of many advanced solid tumors. The main goal is to find a safe dose and see how the body handles the drug, both when given alone and when …
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 01, 2026 23:41 UTC
-
New combo therapy aims to keep advanced pancreatic cancer at bay
Disease control Recruiting nowThis study is testing whether a two-drug combination can help control advanced pancreatic cancer that has spread and cannot be surgically removed. The treatment is given as 'maintenance therapy' to patients whose cancer has stopped growing or shrunk after their initial chemothera…
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Experimental drug offers hope for advanced cancers with no other options
Disease control Recruiting nowThis early-stage trial is testing a new drug called BL-M05D1 in people with advanced cancers that have spread and stopped responding to standard treatments. The study will enroll 120 patients with specific cancers like stomach, pancreatic, and esophageal cancer to determine the s…
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Nano-Drug aims to stop cancer wasting syndrome
Symptom relief Recruiting nowThis study is testing whether a special nano-formulated version of an existing appetite drug (megestrol acetate) can help people with advanced pancreatic cancer gain weight and feel better. It will involve 56 patients who are about to start standard chemotherapy. Half will receiv…
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: Shandong Cancer Hospital and Institute • Aim: Symptom relief
Last updated Apr 01, 2026 23:41 UTC